|
Gomez Garcia LM, Escudero A, Mestre C, Fuster Soler JL, Martinez AP, Vagace Valero JM, Vela M, Ruz B, Navarro A, Fernandez L, Fernandez A, Leivas A, Martinez-Lopez J, Ferreras C, De Paz R, Blanquer M, Galan V, Gonzalez B, Corral D, Sisinni L, Mirones I, Balas A, Vicario JL, Valle P, Borobia AM, Perez-Martinez A. Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):328-337.e1. doi: 10.1016/j.clml.2021.01.013. Epub 2021 Jan 25. PubMed PMID: 33610500.
AÑO: 2021; IF: 2.822
|
|
Minguela A, Vasco-Mogorron MA, Campillo JA, Cabanas V, Remigia MJ, Berenguer M, Garcia-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, de la Rubia J, Teruel AI, Muro M, Periago A. Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. PubMed PMID: 34659897; PubMed Central PMCID: PMC8493371.
AÑO: 2021; IF: 5.942
|
|
Bernal, D. G.; Carpes-Ruiz, M.; Martinez, C.; Garcia-Guillen, A.; Blanquer, M.; Garcia-Hernandez, A.; Alguero, M.; Sackstein, R.; Moraleda, J.. MESENCHYMAL STEM CELL IMMUNOREGULATORY EFFECTS ARE BOOSTED BY CD44 LIGATION. CYTOTHERAPY. 2021; 23(5):S129-S130.
AÑO: 2021; IF: 6.196
|
|
Geijo-Barrientos E, Pastore-Olmedo C, De Mingo P, Blanquer M, Gomez Espuch J, Iniesta F, Iniesta NG, Garcia-Hernandez A, Martin-Estefania C, Barrios L, Moraleda JM, Martinez S. Intramuscular Injection of Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Patients: A Randomized Clinical Trial. Front Neurosci. 2020 Mar 24;14:195. doi: 10.3389/fnins.2020.00195. eCollection 2020. PubMed PMID: 32265627; PubMed Central PMCID: PMC7105864.
AÑO: 2020; IF: 4.677
|
|
Garcia-Bernal D, Palomo M, Martinez CM, Millan-Rivero JE, Garcia-Guillen AI, Blanquer M, Diaz-Ricart M, Sackstein R, Carreras E, Moraleda JM. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease. J Cell Mol Med. 2020 Jul;24(14):8031-8044. doi: 10.1111/jcmm.15434. Epub 2020 Jun 10. PubMed PMID: 32519822; PubMed Central PMCID: PMC7348164.
AÑO: 2020; IF: 5.31
|